Blue Trust Inc’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Blue Trust Inc’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-51	Closed	-$2K	–	2749
2023 Q3	$2K	Sell	51 -579	-92%	-$24.6K	﹤0.01%	1875
2023 Q2	$22K	Sell	630 -3,624	-85%	-$147K	﹤0.01%	1020
2023 Q1	$156K	Buy	4,254 +425	+11%	+$15.4K	﹤0.01%	627
2022 Q4	$180K	Buy	3,829 +1,854	+94%	+$73.3K	﹤0.01%	490
2022 Q3	$142K	Buy	1,975 +501	+34%	+$32.4K	﹤0.01%	418
2022 Q2	$119K	Buy	+1,474	New	+$108K	﹤0.01%	447

Other funds holding SYNH

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Blue Trust Inc's SYNH Position: Q4 2023 in Review

Blue Trust Inc sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2023, closing a stake of 51 shares — an estimated $2K sold.

Blue Trust Inc first reported a position in SYNH in Q2 2022 and held it in 6 quarters. The position peaked at $180K in Q4 2022. 2 funds tracked by Wall St. Rank hold SYNH as of Q4 2023.

Blue Trust Inc reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
Blue Trust Inc sold 51 Syneos Health, Inc. Class A Common Stock shares in Q4 2023, an estimated $2K.
Blue Trust Inc first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2022 and held it in 6 quarters.
Blue Trust Inc's Syneos Health, Inc. Class A Common Stock position peaked at $180K in Q4 2022.
2 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2023.

Based on Blue Trust Inc's 13F filing for Q4 2023, filed 18 Jan 2024.